{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:33:11Z","timestamp":1765233191166,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,19]],"date-time":"2021-09-19T00:00:00Z","timestamp":1632009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.mehy.2021.110684","type":"journal-article","created":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T20:36:05Z","timestamp":1632170165000},"page":"110684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Is digital necrosis in COVID-19 caused by neutrophil extracellular traps: Potential therapeutic strategies"],"prefix":"10.1016","volume":"156","author":[{"given":"Marian","family":"Simka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2021.110684_b0005","first-page":"5769","article-title":"Severe acute dried gangrene in COVID-19 infection: a case report","volume":"24","author":"Novara","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.mehy.2021.110684_b0010","doi-asserted-by":"crossref","unstructured":"Shih L, Ferry AM, Gravina PR, et al. Acute digital necrosis in a patient with Raynaud\u2019s phenomenon and COVID-19 infection. Am Surg 2020; doi: 10.1177\/0003134820979788.","DOI":"10.1177\/0003134820979788"},{"key":"10.1016\/j.mehy.2021.110684_b0015","doi-asserted-by":"crossref","unstructured":"Wang JS, Pasieka HB, Petronic-Rosic V, et al. Digital gangrene as a sign of catastrophic coronavirus disease 2019-related microangiopathy. Plast Reconstr Surg Glob Open 2020;8:e3025.","DOI":"10.1097\/GOX.0000000000003025"},{"issue":"11","key":"10.1016\/j.mehy.2021.110684_b0020","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.16763","article-title":"Catastrophic acute bilateral lower limbs necrosis associated with COVID-19 as a likely consequence of both vasculitis and coagulopathy","volume":"34","author":"Del Giudice","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.mehy.2021.110684_b0025","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jhsa.2020.04.024","article-title":"Digital ischemia in COVID-19 patients: case report","volume":"45","author":"Schultz","year":"2020","journal-title":"J Hand Surg Am"},{"issue":"4","key":"10.1016\/j.mehy.2021.110684_b0030","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jvscit.2020.06.002","article-title":"Skin manifestations of COVID-19 resembling acute limb ischemia","volume":"6","author":"Heald","year":"2020","journal-title":"J Vasc Surg Cases Innov Tech"},{"issue":"1","key":"10.1016\/j.mehy.2021.110684_b0035","first-page":"273","article-title":"Upper extremity arterial thromboembolism in a coronavirus patient. A case report. SN Compr","volume":"3","author":"Scott","year":"2021","journal-title":"Clin Med"},{"issue":"1","key":"10.1016\/j.mehy.2021.110684_b0040","doi-asserted-by":"crossref","first-page":"90","DOI":"10.5551\/jat.57950","article-title":"Ischemic necrosis of lower extremity in COVID-19: A case report","volume":"28","author":"Liu","year":"2021","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.mehy.2021.110684_b0045","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.avsg.2020.12.005","article-title":"Acute limb ischemia in a Peruvian cohort infected by COVID-19","volume":"72","author":"S\u00e1nchez","year":"2021","journal-title":"Ann Vasc Surg"},{"issue":"6","key":"10.1016\/j.mehy.2021.110684_b0050","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1016\/j.jvs.2020.04.483","article-title":"Acute limb ischemia in patients with COVID-19 pneumonia","volume":"72","author":"Bellosta","year":"2020","journal-title":"J Vasc Surg"},{"issue":"570","key":"10.1016\/j.mehy.2021.110684_b0055","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd3876","article-title":"Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19","volume":"12","author":"Zuo","year":"2020","journal-title":"Sci Transl Med"},{"issue":"9","key":"10.1016\/j.mehy.2021.110684_b0060","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.3390\/cells9092079","article-title":"On neutrophil extracellular trap (NET) removal: what we know thus far and why so little","volume":"9","author":"Santocki","year":"2020","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.mehy.2021.110684_b0065","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3390\/ijms22020559","article-title":"Neutrophil extracellular traps and their implications in cardiovascular and inflammatory disease","volume":"22","author":"Klopf","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.mehy.2021.110684_b0070","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000453002","article-title":"Immunothrombosis in acute respiratory distress syndrome: Cross talks between inflammation and coagulation","volume":"93","author":"Frantzeskaki","year":"2017","journal-title":"Respiration"},{"issue":"5","key":"10.1016\/j.mehy.2021.110684_b0075","doi-asserted-by":"crossref","first-page":"H500","DOI":"10.1152\/ajpheart.00381.2014","article-title":"Neutrophil extracellular traps in ischemia-reperfusion injury-induced myocardial no-reflow: therapeutic potential of DNase-based reperfusion strategy","volume":"308","author":"Ge","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"10.1016\/j.mehy.2021.110684_b0080","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ana.24993","article-title":"Neutrophil extracellular traps in ischemic stroke thrombi","volume":"82","author":"Laridan","year":"2017","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.mehy.2021.110684_b0085","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1161\/STROKEAHA.117.019896","article-title":"Thrombus neutrophil extracellular traps content impair tPA-induced thrombolysis in acute ischemic stroke","volume":"49","author":"Ducroux","year":"2018","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.mehy.2021.110684_b0090","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1097\/TA.0000000000002938","article-title":"Hypercoagulability and coronavirus disease 2019-associated hypoxemic respiratory failure: Mechanisms and emerging management paradigms","volume":"89","author":"Yeh","year":"2020","journal-title":"J Trauma Acute Care Surg"},{"issue":"2","key":"10.1016\/j.mehy.2021.110684_b0095","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s11239-020-02324-z","article-title":"Neutrophil extracellular traps and thrombosis in COVID-19","volume":"51","author":"Zuo","year":"2021","journal-title":"J Thromb Thrombolysis"},{"issue":"5","key":"10.1016\/j.mehy.2021.110684_b0100","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/jama.2020.25699","article-title":"Autoantibodies may drive COVID-19 blood clots","volume":"325","author":"Hampton","year":"2021","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.mehy.2021.110684_b0105","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3390\/jcm10020191","article-title":"Proposal of the definition for COVID-19-associated coagulopathy","volume":"10","author":"Iba","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.mehy.2021.110684_b0110","doi-asserted-by":"crossref","unstructured":"Barnes BJ, Adrover JM, Baxter-Stoltzfus A, et al. Targeting potential drivers of COVID-19: Neutrophil extracellular traps. J Exp Med 2020;217:e20200652.","DOI":"10.1084\/jem.20200652"},{"issue":"5","key":"10.1016\/j.mehy.2021.110684_b0115","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s40256-020-00431-z","article-title":"Current overview on hypercoagulability in COVID-19","volume":"20","author":"Singhania","year":"2020","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.mehy.2021.110684_b0120","first-page":"S590","article-title":"Utility of neutrophil-to-lymphocyte ratio, platelets-to-lymphocyte ratio and call score for prognosis assessment in COVID-19 patients","volume":"70","author":"Asghar","year":"2020","journal-title":"Pak Armed Forces Med J"},{"issue":"2","key":"10.1016\/j.mehy.2021.110684_b0125","doi-asserted-by":"crossref","first-page":"106017","DOI":"10.1016\/j.ijantimicag.2020.106017","article-title":"Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line","volume":"56","author":"Ciccullo","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.mehy.2021.110684_b0130","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.clnesp.2020.08.004","article-title":"High neutrophil to lymphocyte ratio as a prognostic marker in COVID-19 patients","volume":"40","author":"Pimentel","year":"2020","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.mehy.2021.110684_b0135","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jgar.2020.07.029","article-title":"Neutrophil-to-lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients","volume":"22","author":"Haghjooy Javanmard","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.mehy.2021.110684_b0140","first-page":"361","article-title":"Neutrophil to lymphocyte ratio and C-reactive protein level as prognostic markers in mild versus severe COVID-19 patients","volume":"13","author":"Vasmehjani","year":"2020","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"10.1016\/j.mehy.2021.110684_b0145","doi-asserted-by":"crossref","DOI":"10.1007\/s00062-020-00992-1","article-title":"COVID-19-associated large vessel stroke in a 28-year-old patient. NETs and platelets possible key players in acute thrombus formation","author":"Boeckh-Behrens","year":"2021","journal-title":"Clin Neuroradiol"},{"issue":"4","key":"10.1016\/j.mehy.2021.110684_b0150","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/jamacardio.2020.7308","article-title":"Assessment of neutrophil extracellular traps in coronary thrombus of a case series of patients with COVID-19 and myocardial infarction","volume":"6","author":"Blasco","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.mehy.2021.110684_b0155","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/bjd.19222","article-title":"Thrombotic occlusive vasculopathy in a skin biopsy from a livedoid lesion of a patient with COVID-19","volume":"183","author":"Llamas-Velasco","year":"2020","journal-title":"D Br J Dermatol"},{"key":"10.1016\/j.mehy.2021.110684_b0160","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ebiom.2016.07.012","article-title":"Lactoferrin suppresses neutrophil extracellular traps release in inflammation","volume":"10","author":"Okubo","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.mehy.2021.110684_b0165","doi-asserted-by":"crossref","unstructured":"Liu X, Li Z, Liu S, et al. Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19. Acta Pharm Sin B 2020;10:1205e1215.","DOI":"10.1016\/j.apsb.2020.04.008"},{"issue":"1","key":"10.1016\/j.mehy.2021.110684_b0170","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-09801-x","article-title":"Adenosine receptor agonism protects against NETosis and thrombosis in antiphospholipid syndrome","volume":"10","author":"Ali","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.mehy.2021.110684_b0175","doi-asserted-by":"crossref","first-page":"102925","DOI":"10.1016\/j.ebiom.2020.102925","article-title":"Vascular occlusion by neutrophil extracellular traps in COVID-19","volume":"58","author":"Leppkes","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.mehy.2021.110684_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmni.2020.100756","article-title":"Preliminary report of in vitro and in vivo effectiveness of dornase alfa on SARS-CoV-2 infection","volume":"37","author":"Okur","year":"2020","journal-title":"New Microbe New Infect"},{"key":"10.1016\/j.mehy.2021.110684_b0185","doi-asserted-by":"crossref","first-page":"120389","DOI":"10.1016\/j.biomaterials.2020.120389","article-title":"Long-acting nanoparticulate DNase-1 for effective suppression of SARS-CoV-2-mediated neutrophil activities and cytokine storm","volume":"267","author":"Lee","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.mehy.2021.110684_b0190","doi-asserted-by":"crossref","first-page":"100689","DOI":"10.1016\/j.nmni.2020.100689","article-title":"Consideration of dornase alfa for the treatment of severe COVID-19 acute respiratory distress syndrome","volume":"35","author":"Earhart","year":"2020","journal-title":"New Microbes New Infect"},{"issue":"07","key":"10.1016\/j.mehy.2021.110684_b0195","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1055\/s-0040-1713152","article-title":"Pharmacological agents targeting thromboinflammation in COVID-19: review and implications for future research","volume":"120","author":"Bikdeli","year":"2020","journal-title":"Thromb Haemost"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987721002036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987721002036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:25:20Z","timestamp":1759692320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987721002036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":39,"alternative-id":["S0306987721002036"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2021.110684","relation":{},"ISSN":["0306-9877"],"issn-type":[{"type":"print","value":"0306-9877"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is digital necrosis in COVID-19 caused by neutrophil extracellular traps: Potential therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2021.110684","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110684"}}